store at low temperature | store at -20°C
Talquetamab (JNJ-64407564)是一种用于多发性骨髓瘤的 T 细胞重定向 GPRC5D 双特异性抗体,具有抗肿瘤活性,通过T 细胞的募集和活化诱导 T 细胞介导的杀死表达 GPRC5 的 MM 细胞。Talquetamab 可用于治疗多发性骨髓瘤 (MM)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,980 | 现货 | ||
2 mg | ¥ 3,190 | 现货 | ||
5 mg | ¥ 5,390 | 现货 | ||
10 mg | ¥ 7,360 | 现货 | ||
25 mg | ¥ 10,900 | 现货 | ||
50 mg | ¥ 14,700 | 现货 | ||
100 mg | ¥ 19,800 | 现货 |
产品描述 | Talquetamab (JNJ-64407564) is a T-cell retargeting GPRC5D bispecific antibody for multiple myeloma with antitumor activity that induces T-cell-mediated killing of GPRC5-expressing MM cells through T-cell recruitment and activation.Talquetamab is used to treat multiple myeloma (MM). |
体外活性 | Talquetamab, at concentrations ranging from 0.00128 to 4.0 μg/mL for 48 hours, effectively induces lysis of multiple myeloma cells. This induction is accompanied by a significant dose-dependent increase in the proportion of activated CD4+ and CD8+ T cells, as well as elevated levels of granule enzyme B and inflammatory cytokines such as IL-6, IL-8, and TNF-α [2]. |
体内活性 | Talquetamab (JNJ-64407564), administered subcutaneously or intravenously at doses ranging from 0.1 to 50 µg, exhibits significant anti-tumor activity in H929 and MM mouse models [1]. |
别名 | JNJ-64407564, JNJ-7564 |
分子量 | N/A |
CAS No. | 2226212-40-2 |
store at low temperature | store at -20°C
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Talquetamab 2226212-40-2 GPCR/G Protein Neuroscience Dopamine Receptor JNJ-64407564 JNJ-7564 Inhibitor inhibitor inhibit